Journal of Pediatric Neurology
DOI: 10.1055/s-0044-1788733
Case Report

Infantile Idiopathic Intracranial Hypertension: Case Report of an 8-Month-Old Child

1   Department of Pediatrics, Ankara Etlik City Hospital, Ankara, Turkey
,
2   Department of Pediatric Emergency, Ankara Etlik City Hospital, Ankara, Turkey
,
2   Department of Pediatric Emergency, Ankara Etlik City Hospital, Ankara, Turkey
,
3   Department of Pediatric Neurology, Ankara Bilkent City Hospital, Ankara, Turkey
,
4   Department of Radiology, Ankara Etlik City Hospital, Ankara, Turkey
,
2   Department of Pediatric Emergency, Ankara Etlik City Hospital, Ankara, Turkey
› Institutsangaben

Abstract

Idiopathic intracranial hypertension (IIH), a clinical disorder also known as pseudotumor cerebri, is characterized by increased intracranial pressure of unknown causes. Although it is most commonly observed in young obese women, IIH can also occur in the pediatric population; however, it is extremely rare in infants. Infants do not typically exhibit characteristic signs and symptoms of IIH, making it challenging to diagnose. Additionally, treatment modalities for this disease remain uncertain. We report an 8-month-old female child admitted to the pediatric emergency department with IIH. Our patient presented initially with fever, vomiting, and diarrhea, and then she developed inability to abduct the left eye. Papilledema was not detected in our patient. Magnetic resonance imaging and lumbar puncture contributed to diagnosis of the patient. Dexamethasone (0.5 mg/kg/d, twice a day) and acetazolamide (5 mg/kg/d) were administered; dexamethasone was stopped at the 48th hour after esotropia had resolved. The patient developed left ptosis in the first month after discharge. Acetazolamide was administered for a duration of 5 months and was discontinued once the patient's eye findings improved. With a sudden onset of neurological findings in a healthy infant with normal neuroimaging, IIH should be considered in the differential diagnosis and cerebrospinal fluid pressure should be measured. The principles of treatment for this disease are based on adult guidelines, but the efficacy of acetazolamide has also been reported in the pediatric population, like in our case.



Publikationsverlauf

Eingereicht: 18. September 2023

Angenommen: 02. Juli 2024

Artikel online veröffentlicht:
30. Juli 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Del Monte F, Bucchino L, Versace A. et al. Infantile idiopathic intracranial hypertension: case report and review of the literature. Ital J Pediatr 2022; 48 (01) 3
  • 2 Boles S, Martinez-Rios C, Tibussek D, Pohl D. Infantile idiopathic intracranial hypertension: a case study and review of the literature. J Child Neurol 2019; 34 (13) 806-814
  • 3 Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81 (13) 1159-1165
  • 4 Masri A, Jaafar A, Noman R, Gharaibeh A, Ababneh OH. Intracranial hypertension in children: etiologies, clinical features, and outcome. J Child Neurol 2015; 30 (12) 1562-1568
  • 5 Fernandez-Pol C, Ben Wallenstein M, Chua I. Case 1: acute-onset vomiting, fever, and bulging fontanelle in a 7-month-old boy. Pediatr Rev 2016; 37 (12) 536-538
  • 6 Goldberg EM. Fever and bulging fontanelle mimicking meningitis in an infant diagnosed with benign intracranial hypertension. Pediatr Emerg Care 2013; 29 (04) 513-514
  • 7 Distelmaier F, Tibussek D, Schneider DT, Mayatepek E. Seasonal variation and atypical presentation of idiopathic intracranial hypertension in pre-pubertal children. Cephalalgia 2007; 27 (11) 1261-1264
  • 8 Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol 2021; 34 (01) 75-83
  • 9 Hartmann AJ, Soares BP, Bruce BB. et al. Imaging features of idiopathic intracranial hypertension in children. J Child Neurol 2017; 32 (01) 120-126
  • 10 Friedman DI. Contemporary management of the pseudotumor cerebri syndrome. Expert Rev Neurother 2019; 19 (09) 881-893